The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association

Samuel S Gidding; Mary Ann Champagne; Sarah D de Ferranti; Joep Defesche; Matthew K Ito; Joshua W Knowles; Brian McCrindle; Frederick Raal; Daniel Rader; Raul D Santos; Maria Lopes-Virella; Gerald F Watts; Anthony S Wierzbicki; American Heart Association Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health

doi:10.1161/CIR.0000000000000297

The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association

Circulation. 2015 Dec 1;132(22):2167-92. doi: 10.1161/CIR.0000000000000297. Epub 2015 Oct 28.

Authors

Samuel S Gidding, Mary Ann Champagne, Sarah D de Ferranti, Joep Defesche, Matthew K Ito, Joshua W Knowles, Brian McCrindle, Frederick Raal, Daniel Rader, Raul D Santos, Maria Lopes-Virella, Gerald F Watts, Anthony S Wierzbicki; American Heart Association Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health

PMID: 26510694
DOI: 10.1161/CIR.0000000000000297

No abstract available

Keywords: AHA Scientific Statements; atherosclerosis; coronary disease; genetic testing; hydroxymethylglutaryl-CoA reductase inhibitors; hyperlipoproteinemia type II; receptors, LDL.

Publication types

Review

MeSH terms

American Heart Association*
Humans
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / genetics
Hyperlipoproteinemia Type II / therapy*
Receptors, LDL / genetics
United States / epidemiology

Substances

Receptors, LDL